Retina Associates of Michigan

What Retina Associates of Michigan does

Retina Associates of Michigan is a private, physician-owned ophthalmology practice that specializes in the diagnosis and management of retinal and vitreous diseases. Operating across three Michigan locations in Grand Blanc (headquarters), Clarkston, and Port Huron, the practice serves adult patients with conditions including macular degeneration, diabetic retinopathy, retinal detachments, macular holes, vascular occlusive diseases, and macular puckers. Founded in 2012 and formerly operating under the name Vitreoretinal Specialists, the practice is staffed by five board-certified, fellowship-trained retina specialists and provides 24/7 emergency retinal coverage.

The clinical offering combines advanced diagnostic imaging (OCT, OCT angiography, fluorescein angiography, ICG angiography, fundus autofluorescence, electroretinography, visual evoked potential), medical therapies (intravitreal injections, retinal laser, photodynamic therapy, cryotherapy), and surgical procedures (vitrectomy, scleral buckling). A distinctive capability is access to the Valeda Light Delivery System, the first FDA-authorized photobiomodulation treatment for dry age-related macular degeneration. Under a Director of Clinical Research, the practice also maintains an active clinical trial portfolio spanning 9+ Phase II–IV studies sponsored by major biopharma companies (Genentech/Roche, Regeneron, EyePoint, Astellas, and the DRCR Network) covering diabetic macular edema, neovascular AMD, geographic atrophy, epiretinal membranes, and uveitis.

Revenue is generated primarily through insurance reimbursements for clinical services, supplemented by compensation from clinical trial sponsors. Patient acquisition relies on a formal physician referral program with downloadable forms, organic self-referrals, a social media presence across Facebook, Twitter, Instagram, LinkedIn, and Yelp, and clinical trial recruitment. The practice is physician-owned with no disclosed external investors, private equity backing, or holding company affiliation.

Name

Retina Associates of Michigan

Legal name

Retina Associates of Michigan

Website

https://retinamichigan.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Retina Associates of Michigan is a private, physician-owned ophthalmology practice operating three Michigan locations, staffed by five fellowship-trained retina specialists delivering medical and surgical care for retinal and vitreous diseases, with an active multi-sponsor clinical research program.

Ownership category

akta.pro rank

Product category

Ophthalmology Services

NAICS

Offices of Optometrists (621320)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

Keywords

• Retinal disease treatment
• Vitreoretinal surgery
• Ophthalmology services
• Diabetic eye care
• Macular degeneration treatment

Headquarters

HQ city

Grand Blanc

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Clinical Services: Medical services provided to patients including consultations, diagnostic testing, treatments, and surgical procedures for retinal conditions. Revenue is generated through insurance reimbursements and patient payments.
2. Clinical Trial Participation: The practice conducts clinical trials and receives compensation for participation. Study participants receive medication coverage for study eye, with the other eye often treated as well. Participants receive stipends ranging from $25-$100 per visit plus travel reimbursement.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Retina Associates of Michigan is a fellowship-trained ophthalmology practice specializing in the diagnosis and management of diseases of the retina and vitreous. The practice provides medical and surgical care for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, macular holes, and other retinal diseases, supported by advanced diagnostic imaging (OCT, OCT Angiography, Fluorescein Angiography, ICG Angiography), therapeutic and surgical procedures (vitrectomy, scleral buckling, intravitreal injections, retinal laser), and the FDA-authorized Valeda Light Delivery System for dry AMD.

Product overview

Retina Associates of Michigan is a fellowship-trained ophthalmology practice specializing in the diagnosis and management of diseases of the retina and vitreous. The practice operates three offices in Michigan (Grand Blanc, Clarkston, and Port Huron) and offers a unified suite of clinical services centered on retinal disease management. The core clinical services include medical and surgical treatment of conditions such as macular degeneration, diabetic retinopathy, retinal vascular disease, retinal detachment, retinal tears, macular holes, and macular puckers. Supporting these services is a portfolio of diagnostic imaging technologies (including OCT, Fluorescein Angiography, ICG Angiography, OCT Angiography, Fundus Photography, Fundus Autofluorescence, Electroretinography, and Visual Evoked Potential), therapeutic procedures (Cryotherapy, Intravitreal Injections, Photodynamic Therapy, Retinal Laser, Scleral Buckling, and Vitrectomy), and an FDA-authorized medical device — the Valeda Light Delivery System (the first and only FDA-authorized photobiomodulation treatment for dry AMD). The practice also maintains a robust portfolio of active and enrolling clinical trials across diabetic macular edema, neovascular AMD, epiretinal membranes, and geographic atrophy, supplemented by a patient-facing online bill payment portal. The products and services function as an integrated clinical care offering rather than a modular software platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Valeda Light Delivery System The first and only FDA-authorized treatment for dry age-related macular degeneration (AMD) that uses photobiomodulation (PBM) to improve vision by targeting mitochondrial dysfunction in the retina, offered to patients with dry AMD.
• Vitrectomy Surgical procedure involving removal of the vitreous gel from the eye to access and treat the retina, used for retinal detachment repair, macular hole closure, and diabetic retinopathy treatment in patients with these retinal conditions.
• Scleral Buckling Surgical technique used to repair retinal detachment by placing a silicone band around the outside of the eye to support the retina, provided to patients with retinal detachment.
• Intravitreal Injections Medication injected directly into the vitreous cavity of the eye to treat conditions such as macular degeneration and diabetic retinopathy in affected patients.
• Retinal Laser Laser treatment used to treat various retinal conditions including diabetic retinopathy, retinal tears, and macular edema in affected patients.
• Photodynamic Therapy Laser-based treatment using a light-activated drug to selectively destroy abnormal blood vessels in the retina, for patients with specific retinal vascular conditions.
• Cryotherapy Cold therapy procedure used in the treatment of certain retinal conditions.
• Optical Coherence Tomography (OCT) High-resolution cross-sectional imaging of the retina used to detect and monitor conditions such as macular degeneration, macular edema, and macular holes in patients with suspected or known retinal disease.
• OCT Angiography Non-invasive imaging technique that visualizes blood flow in the retina and choroid without the need for dye injection, used to assess retinal vascular conditions.
• Fluorescein Angiography Diagnostic imaging technique using fluorescein dye to visualize blood flow in the retina and choroid for diagnosing vascular retinal diseases.
• ICG Angiography Indocyanine green angiography used to image blood flow in the choroidal circulation, complementing fluorescein angiography for certain retinal conditions.
• Electroretinography Diagnostic imaging technology used to assess retinal function by measuring electrical responses of the retina to light stimulation.
• Fundus Autofluorescence Imaging technique used to visualize autofluorescent molecules in the retina, aiding in the diagnosis and monitoring of retinal diseases.
• Fundus Photography Standard photographic imaging of the retina used to document and monitor retinal conditions over time.
• Visual Evoked Potential Neurophysiological test measuring the electrical activity of the visual pathway from the retina to the visual cortex to assess optic nerve and visual pathway function.
• Clinical Trials Program Active enrollment of qualified patients into clinical research studies spanning diabetic macular edema, wet AMD, geographic atrophy, epiretinal membranes, and uveitis, providing participants access to cutting-edge therapies with medication coverage and stipends of $25-$100 per visit plus travel reimbursement.
• Vitrectomy for Floaters Minimally invasive vitrectomy procedure specifically performed to remove bothersome vitreous floaters from the visual field for patients with symptomatic floaters.
• Online Bill Payment Secure online portal enabling patients to pay their account balances using credit cards by entering their account number.

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Regional players

• University of Michigan Kellogg Eye Center: Academic ophthalmology department in Ann Arbor offering comprehensive retinal services including clinical trials. Comparable in Michigan footprint and retinal subspecialty services.
• Henry Ford Ophthalmology: Health-system based ophthalmology program across metro Detroit. Comparable in Michigan geographic overlap; Dr. Singh at RAM holds a Section Chief role at a Henry Ford hospital.
• Cleveland Eye Clinic: Multi-subspecialty ophthalmology group in northeast Ohio. Comparable in Great Lakes regional positioning and broad ophthalmology service mix including retina.

Broad incumbents

• Wills Eye Hospital: Specialty eye hospital in Philadelphia known for retina and vitreous services. Comparable in retina subspecialty depth and clinical research output.
• Retina Consultants of America: National network of retina specialists consolidated under private equity sponsorship. Comparable subspecialty focus at greater scale and with capital backing.
• Bascom Palmer Eye Institute: Top-ranked academic ophthalmology center in Miami with a leading retina service and clinical trial portfolio. Comparable in subspecialty retina care and research orientation at a much larger scale.

Direct peers

• Ophthalmic Consultants of Boston: Large multi-subspecialty ophthalmology group in New England offering retina services among other subspecialties. Comparable as a physician-owned multi-location eye care group.
• Tennessee Retina: Multi-location retina specialty practice in Tennessee. Comparable in multi-site model, retina-only focus, and clinical trial participation.
• Midwest Eye Institute: Multi-specialty ophthalmology group serving Indianapolis and surrounding markets with retinal, cataract, and glaucoma services. Comparable as a regional multi-location ophthalmology practice.
• Charles Retina Institute: Single-specialty retina and vitreous practice in Tennessee offering medical and surgical retinal care. Directly comparable as a physician-owned, fellowship-trained retina specialist group of similar scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/vitreo_retinal
• Facebookfacebook.com/michiganretina
• LinkedInlinkedin.com/company/retinamichigan
• Instagraminstagram.com/vitreoretinalspecialists

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Associates of Michigan